From: Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters
 | Pre | Post |
---|---|---|
n | 14 | |
Age (years) | 40.2 ± 1.7 | |
Body mass index (kg/m2) | 25.9 ± 0.7 | 26.1 ± 0.7 |
Waist circumference (cm) | 89.5 ± 1.8 | 89.0 ± 2.0 |
Biochemical data | Â | Â |
 Total cholesterol (mg/dl) | 217.2 ± 7.1 | 207.6 ± 8.5 |
 HDL cholesterol (mg/dl) | 57.6 ± 3.7 | 57.6 ± 4.3 |
 LDL cholesterol (mg/dl) | 132.6 ± 6.5 | 125.8 ± 8.3 |
 Triglycerides (mg/dl) | 163.7 ± 20.6 | 98.1 ± 11.4* |
 Glucose (mg/dl) | 97.6 ± 2.2 | 98.0 ± 1.8 |
 Insulin (μU/ml) | 7.9 ± 1.9 | 6.5 ± 1.2 |
 HOMA-IR | 1.99 ± 0.56 | 1.57 ± 0.28 |
 HbA1c (%) | 5.5 ± 0.1 | 5.5 ± 0.1 |
 hsCRP (mg/dl) | 0.60 ± 0.17 | 0.75 ± 0.20 |
 HMW-adiponectin (μg/ml) | 2.42 ± 0.23 | 2.31 ± 0.23 |
 FABP4 (ng/ml) | 13.5 ± 1.5 | 11.5 ± 1.1* |